Published Date: 24 Apr 2023
Germany: One mechanism underlying the rise in has been revealed by a research team at the University of Cologne's CECAD Cluster of Excellence in Aging Research.
Read Full NewsA longitudinal study shows that optimal AUDIT-C cutoff values for predicting alcohol-attributable harm vary significantly by age and sex, requiring lower thresholds for older adults and women.
Seladelpar is now recommended by NICE for primary biliary cholangitis, targeting both disease progression and severe itch.
Low-dose naltrexone does not provide real clinical benefit for patients with fibromyalgia compared to placebo, according to a clinical trial.
A large population-based study finds that bone marrow oedema and symphyseal cleft signs are common incidental findings on pelvic MRI and do not correlate with self-reported pain.
Emerging research suggests that menstrual blood may provide valuable diagnostic and biological insights, with potential applications in cancer screening and endometriosis detection.
Emerging research says the steroids aren’t a major driver of gestational diabetes, but impacts vary depending on the patient.
The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows.
1.
After cancer: Study explores caring-healing modalities for survivors
2.
TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share
3.
Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma
4.
US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry
5.
Adjuvant Radiation Boosts High-Risk Bladder Cancer Control
1.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
2.
From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels
3.
Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment
4.
Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs
5.
Nuclear Medicine's Role in Battling Women's Cancers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
3.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Updates on Standard V/S High Risk Myeloma Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation